Efficacy and safety of a new device for intravesical thermochemotherapy in non-grade 3 BCG recurrent NMIBC: a phase I–II study

详细信息    查看全文

• 作者：Francesco Soria ; Paola Milla ; Chiara Fiorito ; Francesca Pisano…
• 关键词：Bladder cancer ; Intravesical chemotherapy ; BCG failure ; Thermochemotherapy ; Device assisted
• 刊名：World Journal of Urology
• 出版年：2016
• 出版时间：February 2016
• 年：2016
• 卷：34
• 期：2
• 页码：189-195
• 全文大小：940 KB
• 参考文献：1.Babjuk M, Burger M, Zigeuner R et al (2013) EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2013. Eur Urol 64(4):639–653CrossRef PubMed
  2.Martin FM, Kamat AM (2009) Definition and management of patients with bladder cancer who fail BCG therapy. Expert Rev Anticancer Ther 9:815–820CrossRef PubMed
  3.Hall MC, Chang SS, Dalbagni G et al (2007) Guideline for the management of nonmuscle invasive bladder cancer (stages Ta, T1 and Tis): 2007 update. J Urol 178(6):2314–2330CrossRef PubMed
  4.Lerner SP, Tangen CM, Sucharew H et al (2009) Failure to achieve a complete response to induction BCG therapy is associated with increased risk of disease worsening and death in patients with high risk non muscle invasive bladder cancer. Urol Oncol 27:155–159PubMedCentral CrossRef PubMed
  5.Gallagher BL, Joudi FN, Maymi JL et al (2008) Impact of previous bacilli Calmette-Guerin failure pattern on subsequent response to bacilli Calmette-Guerin plus interferon intravesical therapy. Urology 71:297–301CrossRef PubMed
  6.Yates DR, Brausi MA, Catto JW et al (2012) Treatment options available for bacillus Calmette-Guérin failure in non-muscle-invasive bladder cancer. Eur Urol 62:1088–1096CrossRef PubMed
  7.Sternberg IA, Dalbagni G, Chen LY et al (2013) Intravesical gemcitabine for high risk, nonmuscle invasive bladder cancer after bacillus Calmette-Guérin treatment failure. J Urol 190(5):1686–1691CrossRef PubMed
  8.Van der Heijden AG, Verhaegh G, Jansen CF et al (2005) Effect of hyperthermia on the cytotoxicity of 4 chemotherapeutic agents currently used for the treatment of transitional cell carcinoma of the bladder: an in vitro study. J Urol 173:1375–1380CrossRef PubMed
  9.Colombo R, Da Pozzo LF, Lev A et al (1996) Neoadjuvant combined microwave induced local hyperthermia and topical chemotherapy versus chemotherapy alone for superficial bladder cancer. J Urol 155:1227–1232CrossRef PubMed
  10.Colombo R, Salonia A, Leib Z et al (2011) Long-term outcomes of a randomized controlled trial comparing thermochemotherapy with mitomycin-C alone as adjuvant treatment for non-muscle-invasive bladder cancer (NMIBC). BJU Int 107(6):912–918CrossRef PubMed
  11.Nativ O, Witjes JA, Hendricksen K et al (2009) Combined thermo-chemotherapy for recurrent bladder cancer after bacillus Calmette-Guerin. J Urol 182:1313–1317CrossRef PubMed
  12.Lammers RJ, Witjes JA, Inman BA et al (2011) The role of a combined regimen with intravesical chemotherapy and hyperthermia in the management of non-muscle-invasive bladder cancer: a systematic review. Eur Urol 60:81–93CrossRef PubMed
  13.Slater SE, Patel P, Viney R et al (2014) The effects and effectiveness of electromotive drug administration and chemohyperthermia for treating non-muscle invasive bladder cancer. Ann R Coll Surg Engl 96(6):415–419CrossRef PubMed
  14.Colombo R, Salonia A, Da Pozzo LF et al (2003) Combination of intravesical chemotherapy and hyperthermia for the treatment of superficial bladder cancer: preliminary clinical experience. Crit Rev Oncol Hematol 47(2):127–139CrossRef PubMed
  15.Trotti A, Colevas AD, Setser A et al (2003) CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment. Semin Radiat Oncol 13(3):176–181CrossRef PubMed
  16.Milla P, Fiorito C, Soria F et al (2014) Intravesical thermo-chemotherapy based on conductive heat: a first pharmacokinetic study with mitomycin C in superficial transitional cell carcinoma patients. Cancer Chemother Pharmacol 73(3):503–509CrossRef PubMed
  17.Kamat AM, Witjes JA, Brausi M et al (2014) Defining and treating the spectrum of intermediate risk nonmuscle invasive bladder cancer. J Urol 192(2):305–315PubMedCentral CrossRef PubMed
  18.Jones G, Cleves A, Wilt TJ et al (2012) Intravesical gemcitabine for non-muscle invasive bladder cancer (Review). Cochrane Database Syst Rev 1:CD00929
  19.Prasad SM, Eyre S, Loughlin KR (2013) Salvage combination intravesical immunotherapy with Bacillus Calmette-Guérin and interferon-α2B: impact on recurrence, progression, and survival. Hosp Pract (1995) 41(4):31-39CrossRef
  20.Dahm-Daphi J, Brammer I, Dikomey E (1997) Heat effects on the repair of DNA double strand breaks in CHO cells. Int J Radiat Biol 72:171–179CrossRef PubMed
  21.Paroni R et al (2001) Effect of local hyperthermia of the bladder on mitomycin C pharmacokinetics during intravesical chemotherapy for the treatment of superficial transitional cell carcinoma. Br J Clin Pharmacol 52:273–278PubMedCentral CrossRef PubMed
  22.Witjes JA, Hendricksen K, Gofrit O et al (2009) Intravesical hyperthermia and mitomycin-C for carcinoma in situ of the urinary bladder: experience of the European Synergo® working party. World J Urol 27:319–324CrossRef
  23.Colombo R, Lev A, Da Pozzo LF et al (1995) A new approach using local combined microwave hyperthermia and chemotherapy in superficial transitional bladder carcinoma treatment. J Urol 153:959–963CrossRef PubMed
  
• 作者单位：Francesco Soria (1)
  Paola Milla (2)
  Chiara Fiorito (1)
  Francesca Pisano (1)
  Filippo Sogni (3)
  Massimiliano Di Marco (4)
  Vincenzo Pagliarulo (5)
  Franco Dosio (2)
  Paolo Gontero (1)
  
  1. Division of Urology, Department of Surgical Sciences, San Giovanni Battista Hospital, University of Studies of Torino, C.so Bramante 88/90, 10126, Turin, Italy
  2. Department of Pharmacology, University of Studies of Torino, Turin, Italy
  3. Urology Clinic, Maggiore della Carità Hospital, Novara, Italy
  4. Urology Unit, Casa di Cura Guarnieri, Rome, Italy
  5. Urology Clinic, Policlinico of Bari, Bari, Italy
  
• 刊物类别：Medicine
• 刊物主题：Medicine & Public Health
  Urology and Andrology
  Nephrology
  Oncology
  
• 出版者：Springer Berlin / Heidelberg
• ISSN：1433-8726

文摘

Purpose We report for the first time the activity and safety of Unithermia® (Elmedical Ltd, Hod-Hasharon, Israel), a novel device for administration of MMC-C with hyperthermia (HT), that employs conductive heating, in a series of non-grade 3 non-muscle-invasive bladder cancer (NMIBC) that failed Bacillus Calmette–Guerin (BCG).